ID

40595

Beschrijving

Extension Study Evaluating the Safety and Efficacy of Subcutaneous RoActemra/Actemra Administration in Patients With Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02165345

Link

https://clinicaltrials.gov/show/NCT02165345

Trefwoorden

  1. 30-04-20 30-04-20 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

30 april 2020

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Juvenile Idiopathic Arthritis NCT02165345

Eligibility Juvenile Idiopathic Arthritis NCT02165345

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
completion of either of the jigsaw studies, study wa28117 (for patients with pcjia) or study wa28118 (for patients with sjia)
Beschrijving

Clinical Trial Specified Completed | Clinical Trial Polyarticular juvenile idiopathic arthritis | Clinical Trial SJIA

Datatype

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0205369
UMLS CUI [1,3]
C0205197
UMLS CUI [2,1]
C0008976
UMLS CUI [2,2]
C4521004
UMLS CUI [3,1]
C0008976
UMLS CUI [3,2]
C1384600
adequate disease control with the use of sc roactemra/actemra, as assessed by the investigator
Beschrijving

Disorder control RoActemra Subcutaneous | Disorder control Actemra Subcutaneous

Datatype

boolean

Alias
UMLS CUI [1,1]
C0920467
UMLS CUI [1,2]
C3272237
UMLS CUI [1,3]
C1522438
UMLS CUI [2,1]
C0920467
UMLS CUI [2,2]
C2740854
UMLS CUI [2,3]
C1522438
written informed consent for study participation obtained from the patient (for patients >/= 18 years old) or the patient's parents or guardian, with assent as appropriate by the patient, depending on the level of the patient's understanding
Beschrijving

Informed Consent | Age | Informed Consent Parent | Informed Consent Guardian

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0001779
UMLS CUI [3,1]
C0021430
UMLS CUI [3,2]
C0030551
UMLS CUI [4,1]
C0021430
UMLS CUI [4,2]
C1274041
for patients of reproductive potential: use of effective contraception as defined by the study protocol
Beschrijving

Females & males of reproductive potential Contraceptive methods

Datatype

boolean

Alias
UMLS CUI [1,1]
C4034483
UMLS CUI [1,2]
C0700589
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
therapy with biologic agents (except roactemra/actemra) in the period between completion of the jigsaw study and screening for the current study
Beschrijving

Biological agents | Exception RoActemra | Exception Actemra

Datatype

boolean

Alias
UMLS CUI [1]
C0005515
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C3272237
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C2740854
concurrent treatment with dmards (including mtx), nsaids, and oral corticosteroids is permitted at the discretion of the investigator
Beschrijving

DMARDs allowed | Methotrexate allowed | NSAIDs allowed | Adrenal Cortex Hormones Oral allowed

Datatype

boolean

Alias
UMLS CUI [1,1]
C0242708
UMLS CUI [1,2]
C0683607
UMLS CUI [2,1]
C0025677
UMLS CUI [2,2]
C0683607
UMLS CUI [3,1]
C0003211
UMLS CUI [3,2]
C0683607
UMLS CUI [4,1]
C0001617
UMLS CUI [4,2]
C1527415
UMLS CUI [4,3]
C0683607
use of live or attenuated vaccines and immunosuppressants, such as cyclosporine and cyclophosphamide, is prohibited
Beschrijving

Vaccines, Attenuated | Immunosuppressive Agents | Cyclosporine | Cyclophosphamide

Datatype

boolean

Alias
UMLS CUI [1]
C0042211
UMLS CUI [2]
C0021081
UMLS CUI [3]
C0010592
UMLS CUI [4]
C0010583
pregnancy or breast-feeding
Beschrijving

Pregnancy | Breast Feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
any significant concurrent medical or surgical conditions or findings that would jeopardize the patient's safety or ability to complete the study, including but not limited to disease of the nervous, renal, hepatic, cardiac, pulmonary, gastric, or endocrine system or any infection
Beschrijving

Comorbidity At risk Patient safety | Operative Surgical Procedures At risk Patient safety | Finding At risk Patient safety | Comorbidity Completion of clinical trial At risk | Operative Surgical Procedures Completion of clinical trial At risk | Finding Completion of clinical trial At risk | Nervous system disorder | Kidney Disease | Liver disease | Heart Disease | Lung disease | Stomach Disease | Endocrine System Disease

Datatype

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C1444641
UMLS CUI [1,3]
C1113679
UMLS CUI [2,1]
C0543467
UMLS CUI [2,2]
C1444641
UMLS CUI [2,3]
C1113679
UMLS CUI [3,1]
C0243095
UMLS CUI [3,2]
C1444641
UMLS CUI [3,3]
C1113679
UMLS CUI [4,1]
C0009488
UMLS CUI [4,2]
C2732579
UMLS CUI [4,3]
C1444641
UMLS CUI [5,1]
C0543467
UMLS CUI [5,2]
C2732579
UMLS CUI [5,3]
C1444641
UMLS CUI [6,1]
C0243095
UMLS CUI [6,2]
C2732579
UMLS CUI [6,3]
C1444641
UMLS CUI [7]
C0027765
UMLS CUI [8]
C0022658
UMLS CUI [9]
C0023895
UMLS CUI [10]
C0018799
UMLS CUI [11]
C0024115
UMLS CUI [12]
C0038354
UMLS CUI [13]
C0014130
history of alcohol, drug, or chemical abuse within 6 months prior to screening
Beschrijving

Substance Use Disorders | Chemical abuse

Datatype

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2]
C0851847
history of atypical tuberculosis (tb) or active tb requiring treatment within 2 years prior to screening
Beschrijving

Tuberculosis Atypical | Tuberculosis Treatment required for

Datatype

boolean

Alias
UMLS CUI [1,1]
C0041296
UMLS CUI [1,2]
C0205182
UMLS CUI [2,1]
C0041296
UMLS CUI [2,2]
C0332121

Similar models

Eligibility Juvenile Idiopathic Arthritis NCT02165345

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Clinical Trial Specified Completed | Clinical Trial Polyarticular juvenile idiopathic arthritis | Clinical Trial SJIA
Item
completion of either of the jigsaw studies, study wa28117 (for patients with pcjia) or study wa28118 (for patients with sjia)
boolean
C0008976 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
C0008976 (UMLS CUI [2,1])
C4521004 (UMLS CUI [2,2])
C0008976 (UMLS CUI [3,1])
C1384600 (UMLS CUI [3,2])
Disorder control RoActemra Subcutaneous | Disorder control Actemra Subcutaneous
Item
adequate disease control with the use of sc roactemra/actemra, as assessed by the investigator
boolean
C0920467 (UMLS CUI [1,1])
C3272237 (UMLS CUI [1,2])
C1522438 (UMLS CUI [1,3])
C0920467 (UMLS CUI [2,1])
C2740854 (UMLS CUI [2,2])
C1522438 (UMLS CUI [2,3])
Informed Consent | Age | Informed Consent Parent | Informed Consent Guardian
Item
written informed consent for study participation obtained from the patient (for patients >/= 18 years old) or the patient's parents or guardian, with assent as appropriate by the patient, depending on the level of the patient's understanding
boolean
C0021430 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0021430 (UMLS CUI [3,1])
C0030551 (UMLS CUI [3,2])
C0021430 (UMLS CUI [4,1])
C1274041 (UMLS CUI [4,2])
Females & males of reproductive potential Contraceptive methods
Item
for patients of reproductive potential: use of effective contraception as defined by the study protocol
boolean
C4034483 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Biological agents | Exception RoActemra | Exception Actemra
Item
therapy with biologic agents (except roactemra/actemra) in the period between completion of the jigsaw study and screening for the current study
boolean
C0005515 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C3272237 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C2740854 (UMLS CUI [3,2])
DMARDs allowed | Methotrexate allowed | NSAIDs allowed | Adrenal Cortex Hormones Oral allowed
Item
concurrent treatment with dmards (including mtx), nsaids, and oral corticosteroids is permitted at the discretion of the investigator
boolean
C0242708 (UMLS CUI [1,1])
C0683607 (UMLS CUI [1,2])
C0025677 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])
C0003211 (UMLS CUI [3,1])
C0683607 (UMLS CUI [3,2])
C0001617 (UMLS CUI [4,1])
C1527415 (UMLS CUI [4,2])
C0683607 (UMLS CUI [4,3])
Vaccines, Attenuated | Immunosuppressive Agents | Cyclosporine | Cyclophosphamide
Item
use of live or attenuated vaccines and immunosuppressants, such as cyclosporine and cyclophosphamide, is prohibited
boolean
C0042211 (UMLS CUI [1])
C0021081 (UMLS CUI [2])
C0010592 (UMLS CUI [3])
C0010583 (UMLS CUI [4])
Pregnancy | Breast Feeding
Item
pregnancy or breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Comorbidity At risk Patient safety | Operative Surgical Procedures At risk Patient safety | Finding At risk Patient safety | Comorbidity Completion of clinical trial At risk | Operative Surgical Procedures Completion of clinical trial At risk | Finding Completion of clinical trial At risk | Nervous system disorder | Kidney Disease | Liver disease | Heart Disease | Lung disease | Stomach Disease | Endocrine System Disease
Item
any significant concurrent medical or surgical conditions or findings that would jeopardize the patient's safety or ability to complete the study, including but not limited to disease of the nervous, renal, hepatic, cardiac, pulmonary, gastric, or endocrine system or any infection
boolean
C0009488 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C1113679 (UMLS CUI [1,3])
C0543467 (UMLS CUI [2,1])
C1444641 (UMLS CUI [2,2])
C1113679 (UMLS CUI [2,3])
C0243095 (UMLS CUI [3,1])
C1444641 (UMLS CUI [3,2])
C1113679 (UMLS CUI [3,3])
C0009488 (UMLS CUI [4,1])
C2732579 (UMLS CUI [4,2])
C1444641 (UMLS CUI [4,3])
C0543467 (UMLS CUI [5,1])
C2732579 (UMLS CUI [5,2])
C1444641 (UMLS CUI [5,3])
C0243095 (UMLS CUI [6,1])
C2732579 (UMLS CUI [6,2])
C1444641 (UMLS CUI [6,3])
C0027765 (UMLS CUI [7])
C0022658 (UMLS CUI [8])
C0023895 (UMLS CUI [9])
C0018799 (UMLS CUI [10])
C0024115 (UMLS CUI [11])
C0038354 (UMLS CUI [12])
C0014130 (UMLS CUI [13])
Substance Use Disorders | Chemical abuse
Item
history of alcohol, drug, or chemical abuse within 6 months prior to screening
boolean
C0038586 (UMLS CUI [1])
C0851847 (UMLS CUI [2])
Tuberculosis Atypical | Tuberculosis Treatment required for
Item
history of atypical tuberculosis (tb) or active tb requiring treatment within 2 years prior to screening
boolean
C0041296 (UMLS CUI [1,1])
C0205182 (UMLS CUI [1,2])
C0041296 (UMLS CUI [2,1])
C0332121 (UMLS CUI [2,2])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial